Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - riboflavine sodium phosphate, quantity: 20.5 mg (equivalent: riboflavine, qty 15 mg); zinc citrate trihydrate, quantity: 32.03 mg (equivalent: zinc, qty 10 mg); magnesium sulfate dihydrate, quantity: 328.19 mg (equivalent: magnesium, qty 51 mg); pyridoxine hydrochloride, quantity: 10 mg (equivalent: pyridoxine, qty 8.2 mg); magnesium carbonate hydrate, quantity: 195.8 mg (equivalent: magnesium, qty 49 mg); ascorbic acid, quantity: 500 mg; calcium pantothenate, quantity: 25 mg (equivalent: calcium pantothenate, qty 2.31 mg; equivalent: pantothenic acid, qty 23 mg); folic acid, quantity: 400 microgram; monophosphothiamine dihydrate, quantity: 18.54 mg (equivalent: thiamine, qty 11.8 mg); biotin, quantity: 150 microgram; nicotinamide, quantity: 50 mg; calcium carbonate, quantity: 244 mg (equivalent: calcium, qty 97.7 mg); cyanocobalamin, quantity: 0.01 mg - tablet, effervescent - excipient ingredients: isomalt; acesulfame potassium; maltodextrin; aspartame; sodium chloride; sodium carbonate; citric acid; sodium bicarbonate; polysorbate 60; mannitol; sorbitol; pregelatinised maize starch; sodium citrate dihydrate; colour; flavour - antioxidant/reduce free radicals formed in the body ; enhance/promote energy levels ; maintain/support energy levels ; enhance/promote/physical endurance/capacity/stamina ; maintain/support physical endurance/capacity/stamina ; helps enhance/promote body energy reserves ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support healthy blood circulation ; enhance/improve/promote immune defence/immunity ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range ; aids/assists the body to cope with environmental stress ; decrease/reduce/relieve symptoms of stress ; decrease/reduce/relieve symptoms of mild anxiety ; helps enhance/improve/promote/increase attention span ; maintain/support mental concentration/focus/clarity ; enhance/improve/promote/increase cognitive performance ; enhance/improve/promote/increase mental endurance/stamina ; enhance/improve/promote/increase mental alertness/wakefulness ; enhance/improve/promote/increase memory/recall ; maintain/support memory/mental recall ; enhance/improve/promote/increase short term memory ; support healthy emotional/mood balance ; maintain/support skin health

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

royce pharma manufacturing sdn. bhd. - riboflavine -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

bimeda amea limited, - vitamin a , vitamin d3 , vitamin e , thiamine , pyridoxine , riboflavine , vitamin b12 , niacinamide , phosphate sodium , d-panthenol , d-biotin , cal - solution for injection - vitamin a 2000 iu/ml, vitamin d3 2000 iu/ml, vitamin e acetate 4 mg/ml, thiamine hydrochloride 10 mg/ml, pyridoxine hydrochloride 5 mg/ml, riboflavine 0.04 mg/ml, nicotinamide 10 mg/ml, vitamin b12 10 mcg/ml, phosphate sodium 1 mg/ml, d-panthenol 1 mg/ml,

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

riboflavine 2mg

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 5 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 10 mg/ml; pyridoxine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. patients requiring parenteral b vitamin therapy who cannot tolerate intramuscular injections. 5. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that iv b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 6. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2 and b6. 7. peripheral neuritis caused by vari

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 100 mg/ml; riboflavine sodium phosphate, quantity: 2 mg/ml; nicotinamide, quantity: 20 mg/ml; dexpanthenol, quantity: 20 mg/ml; pyridoxine hydrochloride, quantity: 40 mg/ml; cyanocobalamin, quantity: 0.4 mg/ml - injection, solution - excipient ingredients: disodium edetate; benzyl alcohol; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7. carpal tunnel syndrome. 8. pernicious anaemia as a result of in situ b12 deficiency. general indications include: 1. angular stomatitis and glossitis have been shown in some instances to respond to t

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 10 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; pyridoxine hydrochloride, quantity: 5 mg/ml; dexpanthenol, quantity: 2.5 mg/ml; nicotinamide, quantity: 25 mg/ml; cyanocobalamin, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium ascorbate, quantity: 113 mg (equivalent: ascorbic acid, qty 100 mg); folic acid, quantity: 0.4 mg; pyridoxine hydrochloride, quantity: 4.9 mg (equivalent: pyridoxine, qty 4 mg); nicotinamide, quantity: 40 mg; cyanocobalamin, quantity: 5 microgram; thiamine nitrate, quantity: 3.1 mg; biotin, quantity: 60 microgram; sodium pantothenate, quantity: 16.5 mg (equivalent: pantothenic acid, qty 15 mg); riboflavine sodium phosphate, quantity: 4.9 mg (equivalent: riboflavine, qty 3.6 mg) - injection, powder for - excipient ingredients: edetate sodium; methyl hydroxybenzoate; glycine - soluvit n is intended as a supplement in intravenous nutrition in order to meet the daily requirements of the water-soluble vitamins in adults, adolescents, children and infants. fat-soluble vitamins should also be administered to patients receiving prolonged parenteral nutrition.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - riboflavine, quantity: 100 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; magnesium stearate; macrogol 400; microcrystalline cellulose; hypromellose - maintain/support energy levels ; aid/assist digestion/breakdown of dietary fat ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral) within normal range ; helps reduce occurrence of mild migraines

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga manufacturing berhad - riboflavine; thiamine mononitrate; nicotinamide -